Kezar Life Sciences, Inc. (KZR) Misses Q1 EPS by 2c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q1 EPS of ($0.31), $0.02 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Aecon wins $1.7B share of Alberta power plant contract
• Lucid reports Q2 output, names new CFO and five other leaders